Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
38,678,767
-
Share change
-
+33,030
-
Total reported value
-
$284,271,973
-
Put/Call ratio
-
93%
-
Price per share
-
$7.35
-
Number of holders
-
85
-
Value change
-
+$314,261
-
Number of buys
-
41
-
Number of sells
-
30
Institutional Holders of ADURO BIOTECH INC - COM (ADRO) as of Q3 2018
As of 30 Sep 2018,
ADURO BIOTECH INC - COM (ADRO) was held by
85 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,678,767 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Vanguard Group Inc, BAILLIE GIFFORD & CO, Aquilo Capital Management, LLC, FMR LLC, CITADEL ADVISORS LLC, STATE STREET CORP, NORTHERN TRUST CORP, and HARVARD MANAGEMENT CO INC.
This page lists
85
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.